News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Huntsman Ronald Kirk
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.49, valued at
$4.9k
|
|
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/28/2022 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $0.5, valued at
$10k
Granted 333,334 options to buy
@ $0.48, valued at
$160k
Granted 150,000 options to buy
@ $0.48, valued at
$72k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
5
| Huntsman Ronald Kirk (CEO) has filed a Form 5 on Vivos Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Huntsman Ronald Kirk reports a 7.6% stake in VIVOS THERAPEUTICS, INC. |
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
SC 13G
| Huntsman Ronald Kirk reports a 9.6% stake in VIVOS THERAPEUTICS, INC. |
| 12/23/2020 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $7.2669, valued at
$7.3k
|
|
| 12/14/2020 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $8.5, valued at
$4.3k
|
|
| 12/10/2020 |
3
| Huntsman Ronald Kirk (Chairman & CEO) has filed a Form 3 on Vivos Therapeutics, Inc. |
|
|